Octave Presents Data Supporting Solution for Multiple Sclerosis
By Daniella Parra Octave announced new data at the Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting 2023, supporting the company’s solution for multiple sclerosis. Researchers assayed 747 patient samples with Octave’s Multiple Sclerosis Disease Activity (MSDA) test, finding eight...